Recruiting OBSERVATIONAL NCT06423950

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Feasibility of Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Conditions Pediatric Cancer

Interventions Peds Evolutionary Tumor Board (pedsETB)

Updated 9 times since 2024 Last updated: Feb 5, 2026 Started: May 1, 2024 Primary completion: Apr 30, 2027 Completion: Apr 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06423950, this observational or N/A phase trial focuses on Pediatric Cancer and remains actively recruiting participants. Sponsored by H. Lee Moffitt Cancer Center and Research Institute, it has been updated 9 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Dec 2025 — Feb 2026 [monthly]

Recruiting
Sep 2025 — Dec 2025 [monthly]

Recruiting
May 2025 — Sep 2025 [monthly]

Recruiting
Mar 2025 — May 2025 [monthly]

Recruiting

▶ Show 4 earlier versions

Oct 2024 — Mar 2025 [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2024 — Jul 2024 [monthly]

Recruiting

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

H. Lee Moffitt Cancer Center and Research Institute
National Pediatric Cancer Foundation

Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tampa, United States